DOCSLIB.ORG

WNT Signaling, the Development of the Sympathoadrenal–Paraganglionic System and Neuroblastoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WNT Signaling, the Development of the Sympathoadrenal–Paraganglionic System and Neuroblastoma Cell. Mol. Life Sci. DOI 10.1007/s00018-017-2685-8 Cellular and Molecular LifeSciences REVIEW WNT signaling, the development of the sympathoadrenal–paraganglionic system and neuroblastoma Jürgen Becker1 · Jörg Wilting1 Received: 6 July 2017 / Revised: 22 September 2017 / Accepted: 11 October 2017 © The Author(s) 2017. This article is an open access publication Abstract Neuroblastoma (NB) is a tumor of the sympa- Abbreviations thoadrenal system arising in children under 15 years of age. ALK Anaplastic lymphoma kinase In Germany, NB accounts for 7% of childhood cancer cases, BMP Bone morphogenetic protein but 11% of cancer deaths. It originates from highly migra- DBH Dopamine beta-hydroxylase tory progenitor cells that leave the dorsal neural tube and DKK Dickkopf (WNT signaling pathway contribute neurons and glial cells to sympathetic ganglia, inhibitor) and chromafn and supportive cells to the adrenal medulla FOXO Forkhead box protein o transcription factor and paraganglia. Clinically, histologically and molecu- FZD Frizzled (G protein-coupled) receptor larly, NBs present as extremely heterogeneous, ranging GSK3β Glycogen synthase kinase 3β from very good to very poor prognosis. The etiology of NB ILK Integrin-linked kinase still remains unclear and needs to be elucidated, however, LGR4/5 Leucine-rich repeat-containing G protein- aberrant auto- and paracrine embryonic cell communica- coupled receptor 4/5 tions seem to be likely candidates to initiate or facilitate the MDR1 Multidrug resistance protein 1 emergence, progression and regression of NB. The wingless- NB(s) Neuroblastoma(s) type MMTV integration site (WNT) family of proteins rep- NC Neural crest resents an evolutionary highly conserved signaling system Neuro2a Mouse-derived neuroblastoma cell line that orchestrates embryogenesis. At least 19 ligands in the NGF Nerve growth factor human, numerous receptors and co-receptors are known, NOG Noggin which control not only proliferation, but also cell polarity, NT3 Neurotrophin-3 migration and diferentiation. Here we seek to interconnect PTK7 Protein tyrosine kinase 7 aspects of WNT signaling with sympathoadrenal and para- ROR1/2 Receptor tyrosine kinase-like orphan ganglionic development to defne new WNT signaling cues receptor-1/-2 in the etiology and progression of NB. R-spondin-1 Secreted protein, interacts with WNT4 RYK Related to receptor tyrosine kinase Keywords Neuroblastoma · Sympathoadrenal system · SFRP1 Secreted frizzled-related protein 1 Paraganglion · Neural crest SOX Sry-related HMG box transcription factor TCF/LEF T-cell factor/lymphoid enhancer factor (transcription factor) TGFBI Transforming growth factor-induced pro- tein h3 = Keratoepithelin, Bigh3 TH Tyrosine hydroxylase * Jürgen Becker TNKS1 Tankyrase1 [email protected]‑goettingen.de TRK-A Tyrosine (tropomyosin) receptor kinase-A 1 Institute of Anatomy and Cell Biology, University Medical School Göttingen, 37075 Göttingen, Germany Vol.:(0123456789)1 3 J. Becker, J. Wilting VANGL2 Van-gogh-like-2 MYCN is the strongest indicator for highly malignant and WNT Wingless-type MMTV integration site therapy-resistant NB. Despite initially successful therapy, family these patients frequently sufer from relapse, and die because of metastasis formation and resistance to chemotherapy (reviewed by [14]). However, although MYCN amplifcation Neuroblastoma is a potent predictor of disease outcome, it afects only about 25% of the patients, illustrating the urgent need for new diag- Neuroblastoma (NB) is a tumor of the sympathetic nervous nostic markers and therapeutic targets in NB. Thereby, inter- system that arises in children under 15 years of age with a disciplinary approaches combining developmental biology frequency of 1:5700. In Germany, NB accounts for 7% of and pediatric oncology of the sympathoadrenal system have childhood cancer cases, but is responsible for approx. 11% been published in the past 50 years, and may still provide of cancer deaths in children [1]. It originates from highly novel hints for new molecular targets for diagnosis and treat- migratory, sympathoadrenal progenitor cells from the neu- ment of NB [15–20]. ral crest that migrate long distances and form the adrenal medulla, paraganglia, as well as paravertebral and preverte- bral sympathetic ganglia (for review see: [2, 3]). It is com- monly accepted to refer to NB as an embryonic tumor [1, The sympathoadrenal–paraganglionic system 3], which becomes evident when looking at the patient’s age. Approximately 45% of NBs are diagnosed at birth or In the embryo, the sympathoadrenal system consists of the within the frst years of life, with a median age at diagnosis sympathetic nervous system, the adrenal medulla and func- of 1.2 years. Even more strikingly, at the age of 10 years, tionally related paraganglia. Unfortunately, the term para- more than 98% of NBs have been presented clinically [1]. ganglion is often also used for glomera, such as the Glomus Histologically and clinically, NBs present heterogeneously, caroticum and the Glomera aortica, which are located along spanning from poorly diferentiated, highly proliferative, the glossopharyngeal and vagal nerves, and represent sen- metastasizing and chemotherapy-resistant tumors with unfa- sory organs (pCO2, pO2, pH). They should not be mixed up vorable prognosis to localized, well-diferentiated, Schwann with the sympathoadrenal–paraganglionic system, despite cell stroma-rich tumors with good response to mild chemo- their common origin from the neural crest [21]. Paraganglia, therapy or diferentiating agents such as retinoic acid, and which are usually located in the retro-peritoneal region are excellent prognosis (reviewed by [4–6]). endocrine organs, which increase the embryos cardiac output Classically, NB are staged into fve groups (1–4, and under hypoxia (e.g., cigarette smoking of mother) by secre- 4S) according to localization, lymph node involvement, tion of catecholamines. They usually regress during early and metastasis formation [7, 8]. Currently, classifcation is years after birth. about to change into a system considering a variety of risk factors, with the aim to facilitate the comparison of diferent – The sympathetic nervous system has two neuronal levels. national studies. Here, the risk groups are divided into L1, The preganglionic, the so-called “frst” neurons of the L2, M and MS [5, 9]. However, both systems emphasize the sympathetic nervous system are located in the (mainly special signifcance of tumors in children up to 18 months thoracic) lateral spinal medulla of segments C8–L2/3. of age. These NBs are grouped into the 4S or MS stage, These neurons are not involved in NB development, as respectively, taking into account that despite metastases to their synaptic transmitter acetylcholine is not found in skin, liver, and to a low extend, also to bone marrow, these NB, and primary NB is never localized in the central tumors are in most cases well curable by mild chemotherapy nervous system. The “second” neuron is located in the and application of diferentiating agents such as retinoids [4, para-vertebral ganglia of the sympathetic trunk, pre- 10]. In general, localized tumors in young patients are highly vertebral ganglia, and pelvic sympathetic ganglia. It is prone to spontaneous diferentiation and regression. As only referred to as postganglionic, which means the axons of a small percentage of these tumors progresses to metastatic these neurons leave the ganglion towards target organs. stages, medical intervention is no longer regarded as the frst – In the adrenal medulla, chromafn, adrenergic (approx. choice, instead observation and waiting (“wait and see”) may 75%) and noradrenergic (approx. 25%) cells are inner- be sufcient [11]. The basis for this type of tumor behavior vated by pre-ganglionic cholinergic neurons [16]. In seems to reside in a natural regression of sympathoadrenal addition, the adrenal medulla hosts small groups of tissue starting at 18 months of age [12, 13]. post-ganglionic neurons, as well as glia-like cells (sus- Even though a multitude of molecules have been found to tentacular cells), and may therefore be considered a dual infuence NB behavior and may help to predict the outcome, sympathetic ganglion [22–25]. Interestingly, this is the amplifcation and/or over-expression of the proto-oncogene location where the majority of primary NBs develop [3]. 1 3 WNT signaling, the development of the sympathoadrenal–paraganglionic system and neuroblastoma – Post-ganglionic sympathetic neurons use noradrenalin as their transmitter, the closely related chromafn cells produce (nor)adrenalin for endocrine purposes. The only exception are the sympathetic axons that supply the der- mal sweat glands, which are cholinergic [26]. Homovan- illic acid and vanillylmandelic acid are degradation prod- ucts of catecholamines, and they are commonly found enriched in the urine of NB patients [27]. These facts, together with further molecular hints that will be discussed later, point out to the sympathoadre- nal–paraganglionic origin of NB. During embryonic devel- opment, the precursor cells of the sympathoadrenal system delaminate from the dorsal neural tube and form the neural crest (Fig. 1). Embryonic development of the sympathoadrenal– paraganglionic system Regarding NB as an embryonic tumor, it is of interest that the progenitors of postganglionic sympathetic neurons and chromafn cells emigrate from the neural crest (NC). Along the craniocaudal axis, the NC can be subdivided into dif- ferent areas: cranial,
Load more

Recommended publications
  • The Crosstalk Between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
    International Journal of Molecular Sciences Review The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication Janine Wörthmüller * and Curzio Rüegg * Laboratory of Experimental and Translational Oncology, Pathology, Department of Oncology, Microbiology and Immunology (OMI), Faculty of Science and Medicine, University of Fribourg, CH-1700 Fribourg, Switzerland * Correspondence: [email protected] (J.W.); [email protected] (C.R.) Received: 31 October 2020; Accepted: 26 November 2020; Published: 30 November 2020 Abstract: Focal adhesion kinase (FAK) and Wnt signaling pathways are important contributors to tumorigenesis in several cancers. While most results come from studies investigating these pathways individually, there is increasing evidence of a functional crosstalk between both signaling pathways during development and tumor progression. A number of FAK–Wnt interactions are described, suggesting an intricate, context-specific, and cell type-dependent relationship. During development for instance, FAK acts mainly upstream of Wnt signaling; and although in intestinal homeostasis and mucosal regeneration Wnt seems to function upstream of FAK signaling, FAK activates the Wnt/β-catenin signaling pathway during APC-driven intestinal tumorigenesis. In breast, lung, and pancreatic cancers, FAK is reported to modulate the Wnt signaling pathway, while in prostate cancer, FAK is downstream of Wnt. In malignant mesothelioma, FAK and Wnt show an antagonistic relationship: Inhibiting FAK signaling activates the Wnt pathway and vice versa. As the identification of effective Wnt inhibitors to translate in the clinical setting remains an outstanding challenge, further understanding of the functional interaction between Wnt and FAK could reveal new therapeutic opportunities and approaches greatly needed in clinical oncology.
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Wnt Signaling in Neuromuscular Junction Development
    Downloaded from http://cshperspectives.cshlp.org/ on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Wnt Signaling in Neuromuscular Junction Development Kate Koles and Vivian Budnik Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605 Correspondence: [email protected] Wnt proteins are best known for their profound roles in cell patterning, because they are required for the embryonic development of all animal species studied to date. Besides regulating cell fate, Wnt proteins are gaining increasing recognition for their roles in nervous system development and function. New studies indicate that multiple positive and negative Wnt signaling pathways take place simultaneously during the formation of verte- brate and invertebrate neuromuscular junctions. Although some Wnts are essential for the formation of NMJs, others appear to play a more modulatory role as part of multiple signaling pathways. Here we review the most recent findings regarding the function of Wnts at the NMJ from both vertebrate and invertebrate model systems. nt proteins are evolutionarily conserved, though important roles for Wnt signaling have Wsecreted lipo-glycoproteins involved in a become known from studies in both the central wide range of developmental processes in all and peripheral nervous system, this article is metazoan organisms examined to date. In ad- concerned with the role of Wnts at the NMJ. dition to governing many embryonic develop- mental processes, Wnt signaling is also involved WNT LIGANDS, RECEPTORS, AND WNT in nervous system maintenance and function, SIGNALING PATHWAYS and deregulation of Wnt signaling pathways oc- curs in many neurodegenerative and psychiatric Wnts and their receptors comprise a large fam- diseases (De Ferrari and Inestrosa 2000; Carica- ily of proteins.
    [Show full text]
  • Human B-Cell Proliferation and Intracellular Signaling: Part 3
    1872 Diabetes Volume 64, June 2015 Andrew F. Stewart,1 Mehboob A. Hussain,2 Adolfo García-Ocaña,1 Rupangi C. Vasavada,1 Anil Bhushan,3 Ernesto Bernal-Mizrachi,4 and Rohit N. Kulkarni5 Human b-Cell Proliferation and Intracellular Signaling: Part 3 Diabetes 2015;64:1872–1885 | DOI: 10.2337/db14-1843 This is the third in a series of Perspectives on intracel- signaling pathways in rodent and human b-cells, with lular signaling pathways coupled to proliferation in pan- a specific focus on the links between b-cell proliferation creatic b-cells. We contrast the large knowledge base in and intracellular signaling pathways (1,2). We highlight rodent b-cells with the more limited human database. what is known in rodent b-cells and compare and contrast With the increasing incidence of type 1 diabetes and that to the current knowledge base in human b-cells. In- the recognition that type 2 diabetes is also due in part variably, the human b-cell section is very brief compared fi b to a de ciency of functioning -cells, there is great ur- with the rodent counterpart, reflecting the still primitive gency to identify therapeutic approaches to expand hu- state of our understanding of mitogenic signaling in hu- b man -cell numbers. Therapeutic approaches might man b-cells. To emphasize this difference, each figure is include stem cell differentiation, transdifferentiation, or divided into two panels, one summarizing rodent b-cell expansion of cadaver islets or residual endogenous signaling and one for human b-cells. Our intended audi- b-cells. In these Perspectives, we focus on b-cell ence includes trainees in b-cell regeneration as well as proliferation.
    [Show full text]
  • Multi-Functional Norrin Is a Ligand for the LGR4 Receptor
    2060 Research Article Multi-functional norrin is a ligand for the LGR4 receptor Cheng Deng1, Pradeep Reddy1, Yuan Cheng1, Ching-Wei Luo2, Chih-Lun Hsiao2 and Aaron J. W. Hsueh1,* 1Program of Reproductive and Stem Cell Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305-5317, USA 2Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University, Taipei 112, Taiwan *Author for correspondence ([email protected]) Accepted 25 January 2013 Journal of Cell Science 126, 2060–2068 ß 2013. Published by The Company of Biologists Ltd doi: 10.1242/jcs.123471 Summary Mammalian LGR4, 5 and 6 are seven-transmembrane receptors that are important for diverse physiological processes. These receptors are orthologous to DLGR2, a Drosophila receptor activated by the burs/pburs heterodimer important for morphogenesis. Although recent studies indicated that four R-spondin proteins are cognate ligands for LGR4, 5 and 6 receptors, several BMP antagonists in vertebrates have been postulated to be orthologous to burs and pburs. Using newly available genome sequences, we showed that norrin is a vertebrate ortholog for insect burs and pburs and stimulates Wnt signaling mediated by LGR4, but not by LGR5 and 6, in mammalian cells. Although norrin could only activate LGR4, binding studies suggested interactions between norrin and LGR4, 5 and 6. Norrin, the Norrie disease gene product, is also capable of activating Wnt signaling mediated by the Frizzled4 receptor and serves as a BMP antagonist. Mutagenesis studies indicated that different norrin mutations found in patients with Norrie disease can be categorized into subgroups according to defects for signaling through the three distinct binding proteins.
    [Show full text]
  • Mechanisms of Wnt Signaling in Development
    P1: APR/ary P2: ARS/dat QC: ARS/APM T1: ARS August 29, 1998 9:42 Annual Reviews AR066-03 Annu. Rev. Cell Dev. Biol. 1998. 14:59–88 Copyright c 1998 by Annual Reviews. All rights reserved MECHANISMS OF WNT SIGNALING IN DEVELOPMENT Andreas Wodarz Institut f¨ur Genetik, Universit¨at D¨usseldorf, Universit¨atsstrasse 1, 40225 D¨usseldorf, Germany; e-mail: [email protected] Roel Nusse Howard Hughes Medical Institute and Department of Developmental Biology, Stanford University, Stanford, CA 94305-5428; e-mail: [email protected] KEY WORDS: Wnt, wingless, frizzled, catenin, signal transduction ABSTRACT Wnt genes encode a large family of secreted, cysteine-rich proteins that play key roles as intercellular signaling molecules in development. Genetic studies in Drosophila and Caenorhabditis elegans, ectopic gene expression in Xenopus, and gene knockouts in the mouse have demonstrated the involvement of Wnts in pro- cesses as diverse as segmentation, CNS patterning, and control of asymmetric cell divisions. The transduction of Wnt signals between cells proceeds in a complex series of events including post-translational modification and secretion of Wnts, binding to transmembrane receptors, activation of cytoplasmic effectors, and, finally, transcriptional regulation of target genes. Over the past two years our understanding of Wnt signaling has been substantially improved by the identifi- cation of Frizzled proteins as cell surface receptors for Wnts and by the finding that -catenin, a component downstream of the receptor, can translocate to the nucleus and function as a transcriptional activator. Here we review recent data that have started to unravel the mechanisms of Wnt signaling.
    [Show full text]
  • Mir-449 Overexpression Inhibits Papillary Thyroid Carcinoma Cell Growth by Targeting RET Kinase-Β-Catenin Signaling Pathway
    INTERNATIONAL JOURNAL OF ONCOLOGY 49: 1629-1637, 2016 miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway ZONGYU LI1*, XIN HUANG2*, JINKAI XU1, QINGHUA SU1, JUN ZHAO1 and JIANCANG MA1 1Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University; 2Department of General Surgery, The Xi'an Central Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China Received May 20, 2016; Accepted July 13, 2016 DOI: 10.3892/ijo.2016.3659 Abstract. Papillary thyroid carcinoma (PTC) is the most miR-449 overexpression inhibited the growth of PTC by inac- common thyroid cancer and represent approximately 80% of tivating the β-catenin pathway. Thus, miR-449 may serve as a all thyroid cancers. The present study is aimed to investigate potential therapeutic strategy for the treatment of PTC. the role of microRNA (miR)-449 in the progression of PTC. Our results revealed that miR-449 was underexpressed in Introduction the collected PTC specimens compared with non-cancerous PTC tissues. Overexpression of miR-449 induced a cell cycle Thyroid cancer is the leading cause of increased morbidity and arrest at G0/G1 phase and inhibited PTC cell growth in vitro. mortality for endocrine malignancies, and papillary thyroid Further studies revealed that RET proto-oncogene (RET) is carcinoma (PTC) accounts for 80% of thyroid cancer cases (1). a novel miR-449 target, due to miR-449 bound directly to Reports have indicated that PTC have a homogeneous molec- its 3'-untranslated region and miR-449 mimic reduced the ular signature during tumorigenesis compared with other protein expression of RET.
    [Show full text]
  • CIRP Promotes the Progression of Non-Small Cell Lung Cancer Through
    Liao et al. Journal of Experimental & Clinical Cancer Research (2021) 40:275 https://doi.org/10.1186/s13046-021-02080-9 RESEARCH Open Access CIRP promotes the progression of non- small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1 Yi Liao1,2†, Jianguo Feng3†, Weichao Sun1, Chao Wu2, Jingyao Li1, Tao Jing4, Yuteng Liang5, Yonghui Qian5, Wenlan Liu1,5* and Haidong Wang2* Abstract Background: Cold-inducible RNA binding protein (CIRP) is a newly discovered proto-oncogene. In this study, we investigated the role of CIRP in the progression of non-small cell lung cancer (NSCLC) using patient tissue samples, cultured cell lines and animal lung cancer models. Methods: Tissue arrays, IHC and HE staining, immunoblotting, and qRT-PCR were used to detect the indicated gene expression; plasmid and siRNA transfections as well as viral infection were used to manipulate gene expression; cell proliferation assay, cell cycle analysis, cell migration and invasion analysis, soft agar colony formation assay, tail intravenous injection and subcutaneous inoculation of animal models were performed to study the role of CIRP in NSCLC cells; Gene expression microarray was used to select the underlying pathways; and RNA immunoprecipitation assay, biotin pull-down assay, immunopurification assay, mRNA decay analyses and luciferase reporter assay were performed to elucidate the mechanisms. The log-rank (Mantel-Cox) test, independent sample T- test, nonparametric Mann-Whitney test, Spearman rank test and two-tailed independent sample T-test were used accordingly in our study. Results: Our data showed that CIRP was highly expressed in NSCLC tissue, and its level was negatively correlated with the prognosis of NSCLC patients.
    [Show full text]
  • The Role of Signaling Pathways in the Development and Treatment of Hepatocellular Carcinoma
    Oncogene (2010) 29, 4989–5005 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 www.nature.com/onc REVIEW The role of signaling pathways in the development and treatment of hepatocellular carcinoma S Whittaker1,2, R Marais3 and AX Zhu4 1Dana-Farber Cancer Institute, Boston, MA, USA; 2The Broad Institute, Cambridge, MA, USA; 3Institute of Cancer Research, London, UK and 4Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA Hepatocellular carcinoma (HCC) is a highly prevalent, malignancy in adults (Pons-Renedo and Llovet, 2003). treatment-resistant malignancy with a multifaceted mole- For the vast majority of patients, HCC is a late cular pathogenesis. Current evidence indicates that during complication of chronic liver disease, and as such, is hepatocarcinogenesis, two main pathogenic mechanisms often associated with cirrhosis. The main risk factors for prevail: (1) cirrhosis associated with hepatic regeneration the development of HCC include infection with hepatitis after tissue damage caused by hepatitis infection, toxins B virus (HBV) or hepatitis C virus (HCV). Hepatitis (for example, alcohol or aflatoxin) or metabolic influ- infection is believed to be the main etiologic factor in ences, and (2) mutations occurring in single or multiple 480% of cases (Anzola, 2004). Other risk factors oncogenes or tumor suppressor genes. Both mechanisms include excessive alcohol consumption, nonalcoholic have been linked with alterations in several important steatohepatitis, autoimmune hepatitis, primary biliary cellular signaling pathways. These pathways are of cirrhosis, exposure to environmental carcinogens (parti- interest from a therapeutic perspective, because targeting cularly aflatoxin B) and the presence of various genetic them may help to reverse, delay or prevent tumorigenesis.
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]